https://micrornasynthesis.com/....the-3-dimensional-tr
Because of bad engraftment and protection concerns regarding mesenchymal stem cell (MSC) therapy, MSC-derived exosomes have emerged as a substitute cell-free therapy for myocardial infarction (MI). However, the diffusion of exosomes out from the infarcted heart following shot in addition to reasonable productivity limit the potential of clinical applications. Here, we created exosome-mimetic extracellular nanovesicles (NVs) produced from iron oxide nanoparticles (IONPs)-incorporated MSCs (IONP-MSCs).
Like
Comment
Share
